| Breakdown | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 168.91M | 158.52M | 178.47M | 183.73M | 173.94M |
| Gross Profit | 69.66M | 70.49M | 84.85M | 83.28M | 84.13M |
| EBITDA | 24.35M | 19.86M | 36.88M | 40.77M | 45.92M |
| Net Income | 5.37M | 2.61M | 17.80M | 24.78M | 28.28M |
Balance Sheet | |||||
| Total Assets | 197.44M | 202.94M | 210.79M | 177.53M | 117.21M |
| Cash, Cash Equivalents and Short-Term Investments | 19.48M | 22.04M | 26.79M | 12.76M | 17.34M |
| Total Debt | 30.33M | 42.88M | 37.92M | 23.54M | 1.04M |
| Total Liabilities | 79.52M | 86.99M | 92.34M | 72.22M | 32.87M |
| Stockholders Equity | 117.92M | 115.96M | 118.45M | 105.32M | 84.35M |
Cash Flow | |||||
| Free Cash Flow | 20.67M | -3.14M | 11.94M | -4.04M | 31.91M |
| Operating Cash Flow | 22.39M | 11.10M | 26.33M | 8.46M | 38.52M |
| Investing Cash Flow | -15.06M | -16.73M | -21.54M | -22.60M | -20.56M |
| Financing Cash Flow | -9.83M | 1.31M | 10.19M | 8.83M | -15.59M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.58B | 23.58 | 6.16% | 1.18% | 9.51% | -31.96% | |
70 Outperform | £60.41M | 7.74 | 10.36% | ― | 15.50% | 314.96% | |
66 Neutral | £123.11M | 18.14 | 4.59% | 1.77% | 6.55% | 106.55% | |
63 Neutral | £527.53M | 11.70 | 7.52% | ― | 13.21% | -54.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £564.15M | 1.55 | -18.75% | ― | -20.36% | 44.33% | |
46 Neutral | £747.36M | -6.05 | -11.61% | 4.48% | -19.03% | -318.35% |
Focusrite plc announced that its non-executive chairman, Philip Dudderidge, and his closely associated person, Jennifer Dudderidge, have gifted a combined 19,266,000 ordinary shares into a sub-fund of The Dudderidge Family Discretionary Settlement 2024, over which they act as trustees. The move consolidates the family’s beneficial interest in approximately 32.54% of Focusrite’s issued share capital without any shares being sold, while legal title to these shares has been transferred from Goldman Sachs International to UBS AG Wealth Management, signalling a restructuring of long-term family ownership and custody arrangements rather than a change in underlying economic control for existing shareholders.
The most recent analyst rating on (GB:TUNE) stock is a Hold with a £229.00 price target. To see the full list of analyst forecasts on Focusrite stock, see the GB:TUNE Stock Forecast page.